Cormorant Asset Management, LP NAMS Holdings History
Cormorant Asset Management, LP's NewAmsterdam Pharma Co NV Holding Summary
As of 2025-03-31, Cormorant Asset Management, LP held 2.83 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $57.83 Mil. This investment constitutes 4.35% of their stock portfolio, and Cormorant Asset Management, LP now holds 2.52% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.
The initial trade took place in 2024Q1. And since then Cormorant Asset Management, LP has made 4 purchases of NAMS, at an average price of $20.32, for a total of 3.25 Mil shares. In addition, there have been 1 sales at an average price of $22.23 for 425,000.00 shares. Based on historical transaction data and NAMS's current price of $22.20, Cormorant Asset Management, LP's estimated gain on his NAMS holdings is $6.11 Mil, reflecting a 9.25% gain to date.
Cormorant Asset Management, LP NAMS ($22.20) Holding Chart
Cormorant Asset Management, LP NAMS ($22.20) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1